Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

AR-träning hos vuxna med ensidig amblyopi

10 november 2026 uppdaterad av: Eye & ENT Hospital of Fudan University

Dichoptic Augmented Reality (AR) träning kontra patchning hos vuxna med ensidig amblyopi

This is a single-center, non-randomized controlled trial to compare the effectiveness of binocular AR training with patching for the treatment of adults with unilateral amblyopia.

Specific Aim 1 (Primary): To compare the improvement of visual acuity in the amblyopic eye between AR training and patching for the treatment of adults with unilateral amblyopia.

Specific Aim 2 (Secondary): To compare the changes of visual functions and pathway selective neural activity in the early visual and cortex subcortical nuclei including the lateral geniculate nucleus between AR training and patching for the treatment of adults with unilateral amblyopia.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

Patching the fellow eye (FE) is typically the first line of amblyopia therapy. Patching treatment has been thought to be effective only when started before the age of eight and might bring limited benifits for adults who have decreased visual cortex plasticity (Bhola et al., 2006). However, recent animal and human studies have demonstrated that visual cortex plasticity and visual functions can be enhanced later in life (Kind et al., 2002; Pineles et al., 2020), paving the way for new strategies for amblyopia treatment.

Dichoptic/binocular digital therapy has been developed with hope to improve visual functions in amblyopia post the critical period. However, no widely accepted binocular treatments with superiority to patching is available in adults with unilateral amblyopia (Pineles et al., 2020; Oscar et al., 2023). Here, we designed an innovative binocular therapy using augmented reality (AR) training, based on neural deficits in amblyopia, in order to achieve better outcomes.

Selective deficits were found in the parvocellular pathway (P pathway) compared to the magnocellular pathway (M pathway) in the monocular processing of visual information in the amblyopic eye (AE) (Wen et al., 2021). In addition to monocular deficits, imbalanced binocular suppression may also play important roles in the visual deficits of amblyopia as suggested by clinical evidence (DeSantis, 2014; Von Noorden, 1996) and psychophysical studies (Baker et al., 2008; Holopigian et al., 1988; Li et al., 2011; Zhou et al., 2013). Based on the neural deficits in unilateral amblyopia, we first apply the push-pull approach (Xu, He & Ooi, 2010; Ooi et al., 2013), which was aimed to reduce sensory eye dominance in previous literatures, into the rebalance of functions of M and P pathways in the AE and the rebalance of binocular interaction, to improve the high spatial detail perception of the AE in daily life under binocular viewing condition, as well as binocular functions.

Using AR technique combined with dichoptic device, images are processed differently and dichopticaly presented to each eye of the patients in real time, same in the content but different in contrast, spatial frequency, temporal frequency, and signal-to-noise ratio, allowing them to interact with the surrounding environment in real time during the visual training. We aim to achieve push-pull in monocular M-P pathways in the AE and interocular P-P pathways in the FE and the AE, in order to selectively improve the function of the P pathway in the AE under binocular viewing condition.

The proposed trial will be conducted in one study sites in China. For the AR training group, patients need to perform AR training for 2 hours per day at home. For the patching group, patients need to patch the FE for 2 hours per day at home.

Studietyp

Interventionell

Inskrivning (Faktisk)

48

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

      • Shanghai, Kina
        • Eye & ENT Hospital of Fudan University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

18 år till 50 år (Vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria:

  1. Aged 18-50 years (including 18 years and 50 years);
  2. Best-corrected visual acuity worse than 20/30 but no worse than 20/200 in the amblyopic eye, interocular difference of 2 or more lines, with the better eye within the normal range;
  3. Patients with deprivation amblyopia should have relieved the deprivation factors such as opacification of the ocular media (e.g. cataract, nonclearing vitreous opacity, corneal opacities) or other occlusion of the visual axis (e.g. blepharoptosis).
  4. Normal binocular alignment including strabismic amblyopia with orthotropia after optical refractive correction or surgical correction, or intermittent exotropia within a range of -15 to 0 prism diopters measured by the prism cover test.
  5. Patients should have been applyng optical refractive correction for more than 3 months before enrollment.

Exclusion Criteria:

  1. Organic eye diseases preventing the establishment of good vision (e.g. ptosis, media opacity, nystagmus, paracentral fixation, acute inflammation like keratitis, optic nerve diseases like glaucoma, retinal diseases);
  2. Lesions of the brain preventing the establishment of good vision (e.g. cortical visual impairment);
  3. A history of ocular surgery (except strabismus surgery) affecting vision (e.g. retinal detachment repair);
  4. A history of ocular trauma affecting vision;
  5. Receiving amblyopia therapy (except wearing refractive correction glasses) within 2 weeks before enrollment;
  6. History of epilepsy or mental illness, or cognitive defects;
  7. Currently taking medications or needing to take medications during the study period that may affect vision;
  8. Contraindications to magnetic resonance imaging such as implantable electronic device, metal implants (e.g. metal dentures, craniofacial titanium plates), claustrophobia and pregnancy.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Behandling
  • Tilldelning: Icke-randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Enda

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: AR training group

Dichoptic augmented reality training with dual-pathway (parvocellular pathway and magnocellular pathway) and interocular push-pull paradigms developed based on neural deficits in adults with unilateral amblyopia.

Dichoptic augmented reality training with dual-pathway (parvocellular pathway and magnocellular pathway) and interocular push-pull paradigms developed based on neural deficits in adults with unilateral amblyopia

Aktiv komparator: Patching group

Conventional patching therapy.

Conventional patching therapy.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in visual acuity at far
Tidsram: 1 week, 1month, 3month, 6month

Best-corrected visual acuity in the amblyopic eye measured at the distance of 2.5 meters using standardized logMAR visual charts.

1 week, 1month, 3month, 6month

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Change in visual acuity at near
Tidsram: 1 week, 1month, 3month, 6month

Best-corrected visual acuity in the amblyopic eye measured at the distance of 2.2 meters using the Freiburg Visual Acuity test.

1 week, 1month, 3month, 6month
Change in visual acuity with single tumbling E
Tidsram: 1 week, 1month, 3month, 6month

Best-corrected uncrowded and crowded visual acuity in the amblyopic eye measured at the distance of 30 centimeters.

1 week, 1month, 3month, 6month
Change in contrast sensitivity
Tidsram: 1 week, 1month, 3month, 6month

Contrast sensitivity in each eye measured with forced-choice test under binocular viewing.

1 week, 1month, 3month, 6month
Change in faxation stability
Tidsram: 1 week, 1month, 3month, 6month

Fixation stability in each eye measured with EyeLink 1000.

1 week, 1month, 3month, 6month
Change in binocular phase combination
Tidsram: 1 week, 1month, 3month, 6month

Binocular integration measured with phase combination test .

1 week, 1month, 3month, 6month
Change in binocular rivalry ratio
Tidsram: 1 week, 1month, 3month, 6month

Binocular rivalry ratio measured with binocular rivalty test

1 week, 1month, 3month, 6month
Change in stereopsis
Tidsram: 1 week, 1month, 3month, 6month

Near stereopsis measured with Titmus Fly Stereotest pattern.

1 week, 1month, 3month, 6month
Change in neural activity corresponding to visual inputs in SSVEP
Tidsram: 1 week, 1month, 3month, 6month

Pathway-selective neural activity in the early visual cortex revealed by SSVEP.

1 week, 1month, 3month, 6month
Change in neural activity corresponding to visual inputs in fMRI
Tidsram: 1 week, 1month, 3month, 6month

Pathway-selective neural activity in the early visual cortex and subcortical nuclei including lateral geniculate nucleus revealed by fMRI.

1 week, 1month, 3month, 6month

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Studiestol: Wen Wen, MD, PhD, Eye & ENT Hospital of Fudan University, Shanghai, China

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Allmänna publikationer

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

25 februari 2023

Primärt slutförande (Faktisk)

20 december 2024

Avslutad studie (Faktisk)

20 december 2024

Studieregistreringsdatum

Först inskickad

22 november 2024

Först inskickad som uppfyllde QC-kriterierna

22 november 2024

Första postat (Faktisk)

26 november 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

12 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

10 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Andra studie-ID-nummer

  • EENTAR20230225

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

IPD-planbeskrivning

We concerns about patient privacy issues and it's better to protect the publication potential.

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera